From: "Biersack, Mary" <Mary.Biersack**At_Symbol_Here**WESTPHARMA.COM>
Subject: [DCHAS-L] monoclonal antibody drug products
Date: Tue, 5 Apr 2016 20:25:08 +0000
Reply-To: DCHAS-L <DCHAS-L**At_Symbol_Here**MED.CORNELL.EDU>
Message-ID: AA020255FC11BE4BA08B0AC8248D7B29767EB945**At_Symbol_Here**usvfmbx02


Hello,

Our chemistry lab tests the containers that hold drug products.  Most of these drug products are humanized recombinant monoclonal antibodies like the drug product Avastin.  If an FDA registered drug product (ready for human use) is derived from human blood (like a monoclonal antibody) is it considered biohazardous and the blood borne pathogen standard applies when our scientists test the container that houses this drug product.  According to NIOSH drugs are considered hazardous if they have any of the following characteristics: Carcinogenicity, Teratogenicity or other developmental toxicity, Reproductive toxicity, Organ toxicity at low doses or Genotoxicity but it doesn’t mention anything about Biohazardous.

Thanks,

Mary

 

Mary Biersack

Lab Safety and Chemical Hygiene Specialist

West Pharmaceutical Services, Inc.

P: +1 610-594-3278

530 Herman O. West Drive | Exton, PA 19341 | United States

 

Find West on Twitter and LinkedIn.


The contents of this message are confidential and may be privileged. If you have received this message in error, please permanently delete it, along with any files that may be attached to this message, without reading, printing, copying, forwarding or otherwise distributing it. Please notify the sender of the error immediately so that we can prevent it from happening again.

Find West on Twitter and LinkedIn.


The contents of this message are confidential and may be privileged. If you have received this message in error, please permanently delete it, along with any files that may be attached to this message, without reading, printing, copying, forwarding or otherwise distributing it. Please notify the sender of the error immediately so that we can prevent it from happening again.

Previous post   |  Top of Page   |   Next post



The content of this page reflects the personal opinion(s) of the author(s) only, not the American Chemical Society, ILPI, Safety Emporium, or any other party. Use of any information on this page is at the reader's own risk. Unauthorized reproduction of these materials is prohibited. Send questions/comments about the archive to secretary@dchas.org.
The maintenance and hosting of the DCHAS-L archive is provided through the generous support of Safety Emporium.